Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finance Watch: Another Mega-Round As Moderna Bucks Biopharma's IPO Trend

Executive Summary

Moderna raised $500m to fund its growing pipeline, choosing once again to stay private rather than pursue an IPO. Also, AvroBio closed a $60m Series B round to advance its gene therapies for lysosomal storage disorders, Seattle Genetics led recent public company financings, and Vical is restructuring.

Advertisement

Related Content

IPO Update: Seven In January As Big Returns, Solid's Slip-Up Contribute To Bubble Concerns
Deal Watch: Sanofi Finds Ideal 'Partner' For Leukine
Seattle Genetics Looking To Improve, Replace Standards Of Care
Finance Watch: Pandion's $55m Series A Funds Localized Bispecifics For Autoimmune Diseases
Iovance Biotherapeutics CEO On TIL Immunotherapy For Solid Tumors
Ultragenyx Gets Commercial Feet Wet With Mepsevii Launch In Sly Syndrome
The Next Roivant Or Fortress? BridgeBio Raises $135m To Spin Out New Companies
Insmed Phase III Date Support Accelerated Approval For ALIS In Rare Lung Disease
Venture Funding Deals: Cell Medica Raises $73.2m, Tango Dances In With $55m
Biopharma Unicorn Moderna Highlights Secretive Pipeline As Investors Await IPO

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100325

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel